Literature DB >> 33073346

Impact of Examined Lymph Node Count for Esophageal Squamous Cell Carcinoma in Patients who Underwent Right Transthoracic Esophagectomy.

Yu-Zhen Zheng1,2, Xiao-Qiang Li3, Jun-Ye Wang1, Hong Yang1, Jing Wen1, Wen-Yu Zhai1, Lian-Xiong Yuan4, Shen-Shen Fu5, Hong-Ying Liao6, Jian-Hua Fu7.   

Abstract

BACKGROUND: The impact of the number of examined lymph nodes (ELNs) on stage correction and prognostication in patients with esophageal squamous cell carcinoma (ESCC) who underwent right transthoracic esophagectomy is still unclear.
METHODS: Patients with ESCC who underwent right transthoracic esophagectomy at Sun Yat-sen University Cancer Center between January 1997 and December 2013 were retrospectively enrolled. The Cox proportional hazards regression model was used to determine the effect of ELN count on overall survival. The impact of ELN count on stage correction was evaluated using the hypergeometric distribution and Bayes theorem and β-binomial distribution estimation, respectively. The threshold of ELNs was determined using the LOWESS smoother and piecewise linear regression.
RESULTS: Among the 875 included patients, greater ELNs were associated with a higher rate of nodal metastasis. Significant association between staging bias and the number of ELNs is only observed through the Bayes method. The ELN count did not impact 90-day mortality but significantly impacted long-term survival (adjusted hazard ratio [aHR] 0.986), especially in those patients with node-negative disease (aHR 0.972). In patients with node-negative disease, cut-point analysis showed a threshold ELN count of 21.
CONCLUSIONS: A greater number of ELNs is associated with more accurate node staging and better long-term survival in resected ESCC patients. We recommended harvesting at least 21 LNs to acquire accurate staging and long-term survival information for patients with declared node-negative disease using the right thoracic approach.

Entities:  

Mesh:

Year:  2020        PMID: 33073346     DOI: 10.1245/s10434-020-09217-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  1 in total

1.  Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma: Three-year Survival of a Prospective, Randomized, Open-label Trial.

Authors:  Bin Li; Hong Hu; Yawei Zhang; Jie Zhang; Longsheng Miao; Longfei Ma; Xiaoyang Luo; Yiliang Zhang; Ting Ye; Hecheng Li; Jianhua Zhou; Yuan Li; Lei Shen; Kuaile Zhao; Min Fan; Zhengfei Zhu; Jialei Wang; Jie Xu; Youjia Deng; Qiong Lu; Huixun Jia; Xinghua Cheng; Hang Li; Yang Zhang; Chenguang Li; Yunjian Pan; Shilei Liu; Haichuan Hu; Longlong Shao; Yihua Sun; Jiaqing Xiang; Haiquan Chen
Journal:  Ann Surg       Date:  2018-05       Impact factor: 12.969

  1 in total
  2 in total

1.  Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1-3N0M0.

Authors:  Lei-Lei Wu; Jiu-Di Zhong; Jia-Li Zhu; Lu Kang; Yang-Yu Huang; Peng Lin; Hao Long; Lan-Jun Zhang; Qi-Long Ma; Li-Hong Qiu; Guo-Wei Ma
Journal:  BMC Cancer       Date:  2022-01-28       Impact factor: 4.430

2.  The Least Nodal Disease Burden Defines the Minimum Number of Nodes Retrieved for Esophageal Squamous Cell Carcinoma.

Authors:  Hanlu Zhang; Xiuji Yan; Yu-Shang Yang; Hong Yang; Yong Yuan; Dong Tian; Yin Li; Zhi-Yong Wu; Yun Wang; Jian-Hua Fu; Long-Qi Chen
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.